124 related articles for article (PubMed ID: 38300021)
21. Effect of SIRT1 Gene on Epithelial-Mesenchymal Transition of Human Prostate Cancer PC-3 Cells.
Cui Y; Li J; Zheng F; Ouyang Y; Chen X; Zhang L; Chen Y; Wang L; Mu S; Zhang H
Med Sci Monit; 2016 Feb; 22():380-6. PubMed ID: 26847404
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of solid lipid nanoparticles-triggered signaling pathways in eukaryotic cells.
Moraes-Lacerda T; de Jesus MB
Colloids Surf B Biointerfaces; 2022 Dec; 220():112863. PubMed ID: 36272282
[TBL] [Abstract][Full Text] [Related]
23. PrLZ regulates EMT and invasion in prostate cancer via the TGF-β1/p-smad2/miR-200 family/ZEB1 axis.
Xie H; Chen J; Ma Z; Gao Y; Zeng J; Chen Y; Yang Z; Xu S
Prostate; 2024 Mar; 84(4):317-328. PubMed ID: 38145367
[TBL] [Abstract][Full Text] [Related]
24. Drug targeting using solid lipid nanoparticles.
Rostami E; Kashanian S; Azandaryani AH; Faramarzi H; Dolatabadi JE; Omidfar K
Chem Phys Lipids; 2014 Jul; 181():56-61. PubMed ID: 24717692
[TBL] [Abstract][Full Text] [Related]
25. Stimulating effect of palmitate and insulin on cell migration and proliferation in PNT1A and PC3 prostate cells: Counteracting role of metformin.
Landim BC; de Jesus MM; Bosque BP; Zanon RG; da Silva CV; Góes RM; Ribeiro DL
Prostate; 2018 Jul; 78(10):731-742. PubMed ID: 29635803
[TBL] [Abstract][Full Text] [Related]
26. Intracellular signaling cascades triggered by the NK1 fragment of hepatocyte growth factor in human prostate epithelial cell line PNT1A.
Pavone LM; Cattaneo F; Rea S; De Pasquale V; Spina A; Sauchelli E; Mastellone V; Ammendola R
Cell Signal; 2011 Dec; 23(12):1961-71. PubMed ID: 21777671
[TBL] [Abstract][Full Text] [Related]
27. Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery.
Bondi ML; Azzolina A; Craparo EF; Lampiasi N; Capuano G; Giammona G; Cervello M
J Drug Target; 2007 May; 15(4):295-301. PubMed ID: 17487698
[TBL] [Abstract][Full Text] [Related]
28. AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling.
Wang B; Gu Y; Hui K; Huang J; Xu S; Wu S; Li L; Fan J; Wang X; Hsieh JT; He D; Wu K
Urol Oncol; 2018 Oct; 36(10):472.e11-472.e20. PubMed ID: 30139661
[TBL] [Abstract][Full Text] [Related]
29. Design and Preparation of Solid Lipid Nanoparticle (SLN)-Mediated DNA Vaccines.
Francis JE; Skakic I; Smooker PM
Methods Mol Biol; 2022; 2412():355-366. PubMed ID: 34918255
[TBL] [Abstract][Full Text] [Related]
30. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
31. AKT/GSK-3β regulates stability and transcription of snail which is crucial for bFGF-induced epithelial-mesenchymal transition of prostate cancer cells.
Liu ZC; Wang HS; Zhang G; Liu H; Chen XH; Zhang F; Chen DY; Cai SH; Du J
Biochim Biophys Acta; 2014 Oct; 1840(10):3096-105. PubMed ID: 25088797
[TBL] [Abstract][Full Text] [Related]
32. Structural investigation and intracellular trafficking of a novel multicomposite cationic solid lipid nanoparticle platform as a pDNA carrier.
Vighi E; Leot E; Montanari M; Mucci A; Hanuskova M; Iannuccelli V
Ther Deliv; 2011 Nov; 2(11):1419-35. PubMed ID: 22826874
[TBL] [Abstract][Full Text] [Related]
33. Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA.
Gómez-Aguado I; Rodríguez-Castejón J; Vicente-Pascual M; Rodríguez-Gascón A; Pozo-Rodríguez AD; Solinís Aspiazu MÁ
Molecules; 2020 Dec; 25(24):. PubMed ID: 33352904
[TBL] [Abstract][Full Text] [Related]
34. Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter.
Vighi E; Montanari M; Ruozi B; Tosi G; Magli A; Leo E
Eur J Pharm Biopharm; 2010 Nov; 76(3):384-93. PubMed ID: 20691262
[TBL] [Abstract][Full Text] [Related]
35. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
[TBL] [Abstract][Full Text] [Related]
36. Cationic solid lipid nanoparticles interfere with the activity of antioxidant enzymes in hepatocellular carcinoma cells.
Doktorovová S; Santos DL; Costa I; Andreani T; Souto EB; Silva AM
Int J Pharm; 2014 Aug; 471(1-2):18-27. PubMed ID: 24836663
[TBL] [Abstract][Full Text] [Related]
37. Restoration of fibroblast growth factor receptor 2IIIb enhances the chemosensitivity of human prostate cancer cells.
Shoji K; Teishima J; Hayashi T; Ohara S; Mckeehan WL; Matsubara A
Oncol Rep; 2014 Jul; 32(1):65-70. PubMed ID: 24839986
[TBL] [Abstract][Full Text] [Related]
38. Formation of solid lipid nanoparticle (SLN)-gene vector complexes for transfection of mammalian cells in vitro.
Rudolph C; Rosenecker J
Cold Spring Harb Protoc; 2012 Mar; 2012(3):357-60. PubMed ID: 22383641
[TBL] [Abstract][Full Text] [Related]
39. Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.
Swami R; Singh I; Jeengar MK; Naidu VG; Khan W; Sistla R
Int J Pharm; 2015; 486(1-2):287-96. PubMed ID: 25839415
[TBL] [Abstract][Full Text] [Related]
40. Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery.
Yu W; Liu C; Ye J; Zou W; Zhang N; Xu W
Nanotechnology; 2009 May; 20(21):215102. PubMed ID: 19423923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
